Evolution Summit 2022 | Marcus Evans | 9 May 2022 | Encore Boston Harbor, 1 Broadway, Everett, MA 02149, USA`

This summit is bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Key topics for 2022
• Exploring The Future Of The Drug Development Industry
A close look into innovative approaches, new technologies and scientific pathways

• Overcoming Key Challenges In Decentralized Clinical Trials
Case studies and timely discussions on how to design and implement DCT successfully

• Championing Vendor Selection And Management
Best practices to choose the right partners, to minimize delays, conflicts and turnover

• Adapting To A Post-Pandemic World
Lessons learned and best strategies to move forward into the future after Covid-19

• Becoming Truly Patient-Centric
A practical guide on how to put patients at the center of your practice, for real

• Harnessing The Power Of Technology To Maximize Results
Implement new tools and resources to upgrade drug development practice

2022 Speakers

ULTIMATE THINKERS:

David Carruthers
Vice President, Clinical Site Management, Clinical Development Operations, Abbvie

Beth Metzheiser
Head of Clinical Operations, Hematology and CRO Collaborations, BMS

Kristine Koontz
Head of US Clinical Operations, GSK

Eileen Doherty
Clinical Operations Solutions Head, The Janssen Pharmaceutical Companies of Johnson & Johnson

COMPELLING PRESENTATIONS:

David Vulcano
Honorary President, Society for Clinical Research Sites

Amy West
Sr. Director, Digital Transformation & Innovation, Novo Nordisk

Daniel Selness
Executive Director, Clinical and Technical Operations, Mitsubishi Tanabe Pharma Development America

John Linnell
State Captain, COPD Foundation and Patient Advocate

Lorena Gomez
Head of Global Study Start Up, PRO Management, and Digital Implementation, Abbvie

Ty Rorick
Head of Research Operations, Duke Clinical Research Institute

P.J. Brooks
Deputy Director, Office of Rare Diseases Research (ORDR), NIH National Center for Advancing Translational Sciences (NCATS)

Hyun Kim
VP Clinical Operations, AOBiome Therapeutics

INTERACTIVE SESSIONS:

Rakesh Dixit, Ph.D., DABT
Cofounder, President and CSO, Regio Biosciences (An AstraZeneca Spin-off Company

Ana Stegic MD
Director of Clinical Operations, Antibe Therapeutics Inc.

Richard Scranton
Chief Medical Officer, Lyndra Therapeutics

Xuefeng Su, MD, PH.D.
Chief Medical Officer, Tasly Pharmaceutical

Steven Thys
Head of Clinical Operations, Innate Pharma

Jeffrey Bornstein
CMO, Eledon Pharmaceutical

DYNAMIC MODERATORS:

Joseph W. Stauffer, DO, MBA, FAPCR
Chief Medical Officer, Antibe Therapeutics & President, Alta Life Sciences, LLC

Karin Gulbrandsen
U.S. Country Head within Global Clinical Operations, Janssen R&D, Pharmaceutical Company of J&J